Agilus Diagnostics has appointed healthcare industry veteran Vijender Singh as its new Managing Director and Chief Executive Officer (MD & CEO), ushering in a new phase of leadership for one of India’s leading diagnostics companies. The appointment comes as the company aims to strengthen its market presence, improve operational efficiency and expand access to quality diagnostic services across the country.
Singh succeeds Dr Anand K, who has stepped down after leading the company for nearly six years. During his tenure, Dr Anand played an important role in expanding Agilus Diagnostics’ footprint and strengthening its position in India’s rapidly growing diagnostics market.
Announcing the appointment, Agilus Diagnostics said Singh brings over three decades of leadership experience across healthcare, diagnostics, consumer healthcare and fast-moving consumer goods (FMCG). His expertise in business transformation, operational excellence and strategic growth is expected to support the company’s next phase of expansion.
Before joining Agilus, Singh served as Chairman and Managing Director of Diagnum Healthcare. He has also held senior leadership roles as Group CEO of Metropolis Healthcare and CEO of Healthians, giving him extensive experience in managing large diagnostic networks.
Earlier in his career, Singh spent nearly ten years with Dr. Lal PathLabs, where he contributed to the company’s expansion and played a key role in its successful public listing. He has also worked with organisations including Jashvik Capital, Ranbaxy Consumer Healthcare, Bausch & Lomb and Blow Plast, building expertise across healthcare and consumer businesses.
Welcoming Singh to the organisation, Dr Ashutosh Raghuvanshi, Managing Director and CEO of Fortis Healthcare and Chairman of Agilus Diagnostics, said his proven leadership in scaling healthcare businesses and driving operational excellence makes him the right choice to lead the company. He added that Agilus will continue focusing on innovation, customer experience and high-quality diagnostic services.
Expressing his enthusiasm, Singh said he was honoured to take over the leadership of Agilus Diagnostics at a time when the diagnostics industry is evolving rapidly. He described the company as a trusted healthcare brand with a strong foundation built on scientific excellence and customer confidence.
He said his immediate priority would be to work closely with employees, healthcare partners and stakeholders to strengthen the company’s capabilities, improve service quality and deliver greater value to patients. Singh also emphasised the importance of innovation and technology in making diagnostic services more accessible and efficient.
Agilus Diagnostics is a subsidiary of Fortis Healthcare and operates one of the country’s largest diagnostic networks. The company has more than 410 laboratories, over 3,700 customer touchpoints and serves patients across more than 1,000 cities. Its services include routine pathology, specialised laboratory testing and advanced diagnostic solutions for hospitals, doctors, corporates and individual patients.
The leadership transition comes at a time when India’s diagnostics sector is witnessing strong growth, driven by rising health awareness, increasing demand for preventive health check-ups, digital healthcare adoption and early disease detection. Companies are also investing in advanced laboratory technologies and expanding their networks to meet growing demand for accurate and timely diagnosis.
Industry observers believe experienced leadership will be crucial as diagnostic companies compete on service quality, technology and patient experience. With his extensive background in building and managing healthcare businesses, Singh is expected to guide Agilus through its next phase of growth while strengthening its focus on operational excellence and innovation.
The appointment takes effect immediately. Agilus Diagnostics said it will continue building on its strengths in quality, reliability and scientific expertise while working to expand its reach and improve access to diagnostic services for patients across India.